Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Rhinovirus as a driver of airway T cell dynamics in children with treatment-refractory recurrent wheeze
Naomi Bryant, Lyndsey M. Muehling, Kristin Wavell, W. Gerald Teague, Judith A. Woodfolk
Naomi Bryant, Lyndsey M. Muehling, Kristin Wavell, W. Gerald Teague, Judith A. Woodfolk
View: Text | PDF
Research Article Immunology Infectious disease

Rhinovirus as a driver of airway T cell dynamics in children with treatment-refractory recurrent wheeze

  • Text
  • PDF
Abstract

Severe asthma in children is notoriously difficult to treat, and its immunopathogenesis is complex. In particular, the contribution of T cells and relationships to antiviral immunity remain enigmatic. Here, we coupled deep phenotyping with machine learning methods to elucidate the dynamics of T cells in the lower airways of children with treatment-refractory recurrent wheeze, and examine rhinovirus (RV) as a driver. Our strategy revealed a T cell landscape dominated by type 1 and type 17 CD8+ signatures. Interrogation of phenotypic relationships coupled with trajectory mapping identified T cell migratory and differentiation pathways spanning the blood and airways that culminated in tissue residency, and involved transitions between type 1 and type 17 tissue-resident types. These dynamics were reflected in cytokine polyfunctionality. Use of machine learning tools to cross-compare T cell populations that were enriched in the airways of RV-positive children with those induced in the blood following experimental RV challenge precisely pinpointed RV-responsive signatures that contributed to T cell migratory and differentiation pathways. Despite their rarity, these signatures were also detected in the airways of RV-negative children. Together, our results underscore the aberrant nature of type 1 immunity in the airways of children with recurrent wheeze, and implicate an important viral trigger as a driver.

Authors

Naomi Bryant, Lyndsey M. Muehling, Kristin Wavell, W. Gerald Teague, Judith A. Woodfolk

×

Figure 6

RV-related signatures map to T cell differentiation pathways in the lower airways.

Options: View larger image (or click on image) Download as PowerPoint
RV-related signatures map to T cell differentiation pathways in the lowe...
(A) Projection of T-REX populations 1–3 on a PHATE map generated on CD3+ cells from matched blood and BAL (64 samples). (B and C) PHATE maps with overlay of PhenoGraph clusters related to T-REX populations. Heatmaps show marker expression profiles for T-REX populations and related PhenoGraph clusters. Black squares on heatmaps contain markers expressed on all populations. Blue/gray annotation on the left of each heatmap denotes the proportion of cells in each population derived from BAL or blood. (D) Frequencies of PhenoGraph cluster related to T-REX 1–4 in the pediatric cohort. Colored symbols denote patients positive for other viruses (green, n = 3), RV+ patients (red, n = 10), patients negative for any virus (gray, n = 15), and patients who received a biologic (yellow, n = 4). Mean ± SEM.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts